Mark Packer, MD
Plastic Surgery within the Head & Neck · Saint Louis, MONPI 1760470686
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $996 of the $1,655 with a category attached, or 60.2%. 19 manufacturers reported payments, led by Med-el Corporation at 41.0% of the total. Reporting peaked in 2019 at $851 and has fallen 74.4% since, to $218 in 2025.
Across 42 payments — averaging $39.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Med-el Corporation$679
- Regeneron Healthcare Solutions, Inc.$209
- Optinose US, Inc.$132
- Johnson & Johnson$122
- Acclarent, Inc$100
- GSK$83
- plus $330 from 13 others
What the payments were for
- Travel & lodging$65940%
- Food & beverage$99660%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Med-el Corporation | 4 | $679 |
| Regeneron Healthcare Solutions, Inc. | 5 | $209 |
| Optinose US, Inc. | 8 | $132 |
| Johnson & Johnson | 1 | $122 |
| Acclarent, Inc | 3 | $100 |
| GSK | 4 | $83 |
| Sanofi | 2 | $50 |
| Aerin Medical Inc. | 3 | $47 |
| Integra Lifesciences Corporation | 1 | $40 |
| KARL Storz Endoscopy-america | 1 | $25 |
| Acera Surgical, Inc. | 1 | $24 |
| Stryker | 2 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Osiris Therapeutics Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Olympus America Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic surgery within the head & neck providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 11 | $6,782 |
| Fluocinolone Acetonide Oil | 59 | $2,403 |
| Azelastine Hcl | 96 | $2,325 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 42 | $2,102 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 38 | $1,787 |
| Pantoprazole Sodium | 136 | $1,656 |
| Fluticasone Propionate | 142 | $1,493 |
| Ipratropium Bromide | 23 | $754 |
| Famotidine | 23 | $670 |
| Ofloxacin | 26 | $628 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 11 | $547 |
| Levocetirizine Dihydrochloride | 28 | $470 |
| Doxycycline Hyclate | 33 | $405 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $366 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 41 | $309 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $132 | $6,78211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few plastic surgery within the head & neck providers in Missourion file to place this against a meaningful peer group, so we don't.
Other plastic surgery within the head & neck in Saint Louis
- Craig BuchmanSaint Louis$534K
- Laxmeesh NayakSaint Louis$71K
- James BoydSaint Louis$2K
- John ChiCreve Coeur$11K
- John BarclayLiberty$1K
- Gregory BranhamCreve Coeur$1K
- Michael BaysBranson$460
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.